Bonita David P
SEC insider (Form 3/4/5 filer). CIK 0001572451. Director at ImageneBio, Inc. (IMA) and 2 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in WILMINGTON, DE.
Companies Bonita David P has filed insider reports for
- ImageneBio, Inc. (IMA): Director
- Prelude Therapeutics Inc (PRLD): Director, 10% Owner
- Third Harmonic Bio, Inc. (THRD): Director
Bonita David P
CIK: 0001572451
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 16, 2026IMA
ImageneBio, Inc.
AwardDirectStock Option (right to buy)
15.6K shares- - Jun 9, 2026PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
38K shares- - Apr 21, 2026PRLD
Prelude Therapeutics Inc
PurchaseIndirect1.7M shares at avg. $4.44$7.5M - Apr 21, 2026PRLD
Prelude Therapeutics Inc
PurchaseIndirect1.1M shares at avg. $4.44$5.0M - Apr 14, 2026IMA
ImageneBio, Inc.
PurchaseIndirectPre-Funded Warrants (right to buy)
336.6K shares- - Apr 14, 2026IMA
ImageneBio, Inc.
PurchaseIndirectPre-Funded Warrants (right to buy)
384.7K shares- - Aug 11, 2025THRD
Third Harmonic Bio, Inc.
OtherDirect5.8M shares- - Jul 25, 2025IMA
ImageneBio, Inc.
PurchaseIndirect83.6K shares at avg. $29.90$2.5M - Jul 25, 2025IMA
ImageneBio, Inc.
ExerciseDirect379 shares- - Jun 12, 2025PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
38K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  IMA ImageneBio, Inc. | Award Stock Option (right to buy) | 15,600 | - | - | Direct |
| Jun 9, 2026 |  PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Apr 21, 2026 | PRLD Prelude Therapeutics Inc | Purchase | 1,689,189 | $4.44 | $7,499,999 | Indirect |
| Apr 21, 2026 | PRLD Prelude Therapeutics Inc | Purchase | 1,126,126 | $4.44 | $4,999,999 | Indirect |
| Apr 14, 2026 | IMA ImageneBio, Inc. | Purchase Pre-Funded Warrants (right to buy) | 336,603 | - | - | Indirect |
| Apr 14, 2026 | IMA ImageneBio, Inc. | Purchase Pre-Funded Warrants (right to buy) | 384,689 | - | - | Indirect |
| Aug 11, 2025 |  THRD Third Harmonic Bio, Inc. | Other | 5,779,071 | - | - | Direct |
| Jul 25, 2025 | IMA ImageneBio, Inc. | Purchase | 83,611 | $29.90 | $2,499,969 | Indirect |
| Jul 25, 2025 | IMA ImageneBio, Inc. | Exercise | 379 | - | - | Direct |
| Jun 12, 2025 | PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 38,000 | - | - | Direct |
1-10 of 10 transactions